Table of Content

1 Industrial Chain Overview

• 1.1 Chronic Idiopathic Constipation Drugs Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Chronic Idiopathic Constipation Drugs
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 Linaclotide
  • 1.3.2 Lubiprostone
  • 1.3.3 Others
• 1.4 End-Use List
  • 1.4.1 Demand in Hospital Pharmacies
  • 1.4.2 Demand in Retail Pharmacies
  • 1.4.3 Demand in Online Pharmacies
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Pfizer Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 Glaxosmithkline Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Roche Holding AG Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Sanofi Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Bayer AG Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 Merck Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Eli Lilly Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Allergens Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 Chugai Pharmaceutical Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 Ferring International Center S.A Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning
    • 3.2.11 Synergy Pharmaceuticals Overview
      • 3.2.11.1 Product Specifications
      • 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.11.3 Recent Developments
      • 3.2.11.4 Future Strategic Planning
    • 3.2.12 Salix Pharmaceuticals Ltd Overview
      • 3.2.12.1 Product Specifications
      • 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.12.3 Recent Developments
      • 3.2.12.4 Future Strategic Planning
    • 3.2.13 Sucampo Pharmaceuticals Inc Overview
      • 3.2.13.1 Product Specifications
      • 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.13.3 Recent Developments
      • 3.2.13.4 Future Strategic Planning
    • 3.2.14 Ironwood Pharmaceuticals Inc Overview
      • 3.2.14.1 Product Specifications
      • 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.14.3 Recent Developments
      • 3.2.14.4 Future Strategic Planning
    • 3.2.15 Valeant Pharmaceuticals International Overview
      • 3.2.15.1 Product Specifications
      • 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.15.3 Recent Developments
      • 3.2.15.4 Future Strategic Planning
    • 3.2.16 Daiichi Sankyo Overview
      • 3.2.16.1 Product Specifications
      • 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.16.3 Recent Developments
      • 3.2.16.4 Future Strategic Planning
    • 3.2.17 Cosmo Pharmaceuticals SA Overview
      • 3.2.17.1 Product Specifications
      • 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.17.3 Recent Developments
      • 3.2.17.4 Future Strategic Planning
    • 3.2.18 Progenics Pharmaceuticals Inc Overview
      • 3.2.18.1 Product Specifications
      • 3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.18.3 Recent Developments
      • 3.2.18.4 Future Strategic Planning
    • 3.2.19 Theravance Biopharma Inc Overview
      • 3.2.19.1 Product Specifications
      • 3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.19.3 Recent Developments
      • 3.2.19.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in Linaclotide
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in Lubiprostone
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in Others
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Hospital Pharmacies
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Retail Pharmacies
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Online Pharmacies
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Pfizer Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Glaxosmithkline Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Glaxosmithkline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Roche Holding AG Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Roche Holding AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sanofi Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Bayer AG Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Bayer AG (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Merck Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Eli Lilly Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Eli Lilly (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Allergens Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Allergens (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Chugai Pharmaceutical Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Chugai Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Ferring International Center S.A Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Ferring International Center S.A (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Synergy Pharmaceuticals Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Synergy Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Salix Pharmaceuticals Ltd Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Salix Pharmaceuticals Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sucampo Pharmaceuticals Inc Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Sucampo Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Ironwood Pharmaceuticals Inc Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Valeant Pharmaceuticals International Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Daiichi Sankyo Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Cosmo Pharmaceuticals SA Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Progenics Pharmaceuticals Inc Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Theravance Biopharma Inc Overview List

        Table Chronic Idiopathic Constipation Drugs Business Operation of Theravance Biopharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Chronic Idiopathic Constipation Drugs Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in Linaclotide , 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Linaclotide , 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Lubiprostone , 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Lubiprostone , 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Online Pharmacies, 2015-2018, in Volume

According to 99Strategy, the Global Chronic Idiopathic Constipation Drugs Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Chronic Idiopathic Constipation Drugs market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Pfizer 
Glaxosmithkline 
Roche Holding AG 
Sanofi 
Bayer AG 
Merck 
Eli Lilly 
Allergens 
Chugai Pharmaceutical 
Ferring International Center S.A 
Synergy Pharmaceuticals 
Salix Pharmaceuticals Ltd 
Sucampo Pharmaceuticals Inc 
Ironwood Pharmaceuticals Inc 
Valeant Pharmaceuticals International 
Daiichi Sankyo 
Cosmo Pharmaceuticals SA 
Progenics Pharmaceuticals Inc 
Theravance Biopharma Inc
Key Product Type
Linaclotide 
Lubiprostone 
Others
Market by Application
Hospital Pharmacies 
Retail Pharmacies 
Online Pharmacies
Main Aspects covered in the Report
Overview of the Chronic Idiopathic Constipation Drugs market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development